Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
University of Washington
OHSU Knight Cancer Institute
City of Hope Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
University of California, San Francisco
Columbia University
Mayo Clinic
Institut Paoli-Calmettes
Barbara Ann Karmanos Cancer Institute
Gustave Roussy, Cancer Campus, Grand Paris
UMC Utrecht
University of Pittsburgh
Groupe Oncologie Radiotherapie Tete et Cou